Novel Therapies for Metabolic Complications in Patients With Lipodystrophies.

Trial Profile

Novel Therapies for Metabolic Complications in Patients With Lipodystrophies.

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Cholic acid; Leptin; Pioglitazone
  • Indications Diabetes mellitus; Fatty liver; Hypertriglyceridaemia; Insulin resistance; Lipodystrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Jun 2013 Planned end date changed from 1 Aug 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov.
    • 02 Aug 2011 Planned end date changed from 1 Aug 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top